| UniProt ID | PIGT_HUMAN | |
|---|---|---|
| UniProt AC | Q969N2 | |
| Protein Name | GPI transamidase component PIG-T | |
| Gene Name | PIGT | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 578 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type I membrane protein . |
|
| Protein Description | Component of the GPI transamidase complex. Essential for transfer of GPI to proteins, particularly for formation of carbonyl intermediates.. | |
| Protein Sequence | MAAAMPLALLVLLLLGPGGWCLAEPPRDSLREELVITPLPSGDVAATFQFRTRWDSELQREGVSHYRLFPKALGQLISKYSLRELHLSFTQGFWRTRYWGPPFLQAPSGAELWVWFQDTVTDVDKSWKELSNVLSGIFCASLNFIDSTNTVTPTASFKPLGLANDTDHYFLRYAVLPREVVCTENLTPWKKLLPCSSKAGLSVLLKADRLFHTSYHSQAVHIRPVCRNARCTSISWELRQTLSVVFDAFITGQGKKDWSLFRMFSRTLTEPCPLASESRVYVDITTYNQDNETLEVHPPPTTTYQDVILGTRKTYAIYDLLDTAMINNSRNLNIQLKWKRPPENEAPPVPFLHAQRYVSGYGLQKGELSTLLYNTHPYRAFPVLLLDTVPWYLRLYVHTLTITSKGKENKPSYIHYQPAQDRLQPHLLEMLIQLPANSVTKVSIQFERALLKWTEYTPDPNHGFYVSPSVLSALVPSMVAAKPVDWEESPLFNSLFPVSDGSNYFVRLYTEPLLVNLPTPDFSMPYNVICLTCTVVAVCYGSFYNLLTRTFHIEEPRTGGLAKRLANLIRRARGVPPL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 78 | Phosphorylation | KALGQLISKYSLREL HHHHHHHHHHCCCHH | 33.85 | 24719451 | |
| 81 | Phosphorylation | GQLISKYSLRELHLS HHHHHHHCCCHHHCC | 25.37 | 24719451 | |
| 88 | Ubiquitination | SLRELHLSFTQGFWR CCCHHHCCCCCCCCC | 18.59 | 29967540 | |
| 89 | Ubiquitination | LRELHLSFTQGFWRT CCHHHCCCCCCCCCC | 8.12 | 29967540 | |
| 96 | Ubiquitination | FTQGFWRTRYWGPPF CCCCCCCCCCCCCCC | 20.78 | 29967540 | |
| 103 | Ubiquitination | TRYWGPPFLQAPSGA CCCCCCCCCCCCCCC | 9.94 | 21890473 | |
| 104 | Ubiquitination | RYWGPPFLQAPSGAE CCCCCCCCCCCCCCE | 5.38 | 21963094 | |
| 134 | Ubiquitination | WKELSNVLSGIFCAS HHHHHHHHHHHHHHC | 4.55 | 29967540 | |
| 135 | Ubiquitination | KELSNVLSGIFCASL HHHHHHHHHHHHHCC | 26.09 | 29967540 | |
| 142 | Ubiquitination | SGIFCASLNFIDSTN HHHHHHCCCEECCCC | 3.01 | 29967540 | |
| 150 | Ubiquitination | NFIDSTNTVTPTASF CEECCCCCCCCCCCC | 26.33 | 21963094 | |
| 156 | Phosphorylation | NTVTPTASFKPLGLA CCCCCCCCCCCCCCC | 35.96 | 24719451 | |
| 164 | N-linked_Glycosylation | FKPLGLANDTDHYFL CCCCCCCCCCCCEEE | 58.73 | 19159218 | |
| 171 (in isoform 2) | Ubiquitination | - | 3.01 | 21890473 | |
| 190 | Ubiquitination | TENLTPWKKLLPCSS CCCCCCHHHHCCCCC | 34.44 | 29967540 | |
| 191 | Ubiquitination | ENLTPWKKLLPCSSK CCCCCHHHHCCCCCH | 51.92 | 29967540 | |
| 198 | Ubiquitination | KLLPCSSKAGLSVLL HHCCCCCHHHHHHHH | 30.13 | 29967540 | |
| 206 | Ubiquitination | AGLSVLLKADRLFHT HHHHHHHHHHHHCCC | 44.04 | 21963094 | |
| 235 | Phosphorylation | NARCTSISWELRQTL CCCCCCCCCHHHHHH | 17.79 | 24719451 | |
| 237 | Ubiquitination | RCTSISWELRQTLSV CCCCCCCHHHHHHHH | 27.55 | 29967540 | |
| 241 | Phosphorylation | ISWELRQTLSVVFDA CCCHHHHHHHHEEEE | 17.99 | 20068231 | |
| 243 | Phosphorylation | WELRQTLSVVFDAFI CHHHHHHHHEEEEEH | 21.44 | 20068231 | |
| 251 | Phosphorylation | VVFDAFITGQGKKDW HEEEEEHHCCCCCCC | 19.59 | 20068231 | |
| 259 | Phosphorylation | GQGKKDWSLFRMFSR CCCCCCCHHHHHHHC | 27.97 | 20068231 | |
| 263 (in isoform 4) | Ubiquitination | - | 2.54 | 21890473 | |
| 263 | Ubiquitination | KDWSLFRMFSRTLTE CCCHHHHHHHCCCCC | 2.54 | 21890473 | |
| 283 | Ubiquitination | SESRVYVDITTYNQD CCCEEEEEEEEECCC | 18.15 | 29967540 | |
| 291 | N-linked_Glycosylation | ITTYNQDNETLEVHP EEEECCCCCEEEECC | 34.09 | UniProtKB CARBOHYD | |
| 301 | O-linked_Glycosylation | LEVHPPPTTTYQDVI EEECCCCCCCCCCEE | 37.23 | OGP | |
| 308 | Ubiquitination | TTTYQDVILGTRKTY CCCCCCEECCCCCEE | 3.85 | 29967540 | |
| 309 | Ubiquitination | TTYQDVILGTRKTYA CCCCCEECCCCCEEH | 6.03 | 21890473 | |
| 309 | Ubiquitination | TTYQDVILGTRKTYA CCCCCEECCCCCEEH | 6.03 | 21890473 | |
| 327 | N-linked_Glycosylation | LLDTAMINNSRNLNI HHHHHHHCCCCCEEE | 27.60 | UniProtKB CARBOHYD | |
| 339 | Ubiquitination | LNIQLKWKRPPENEA EEEEEEECCCCCCCC | 54.14 | 29967540 | |
| 354 | Ubiquitination | PPVPFLHAQRYVSGY CCCCEEEEEEECCCC | 9.55 | 29967540 | |
| 365 | Ubiquitination | VSGYGLQKGELSTLL CCCCCCCCCCCCHHE | 60.44 | 23000965 | |
| 365 (in isoform 1) | Ubiquitination | - | 60.44 | 21890473 | |
| 405 | Ubiquitination | HTLTITSKGKENKPS EEEEEEECCCCCCCC | 66.41 | - | |
| 410 | Ubiquitination | TSKGKENKPSYIHYQ EECCCCCCCCEECCC | 36.11 | 29967540 | |
| 509 | Phosphorylation | SNYFVRLYTEPLLVN CCEEEEEECCCEEEC | 9.86 | - | |
| 510 | Phosphorylation | NYFVRLYTEPLLVNL CEEEEEECCCEEECC | 35.40 | - | |
| 563 | Ubiquitination | PRTGGLAKRLANLIR CCCCCHHHHHHHHHH | 53.65 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PIGT_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PIGT_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIGT_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GPAA1_HUMAN | GPAA1 | physical | 11483512 | |
| PIGU_HUMAN | PIGU | physical | 22939629 | |
| ERLEC_HUMAN | ERLEC1 | physical | 26344197 | |
| UBP54_HUMAN | USP54 | physical | 28514442 | |
| TNIP1_HUMAN | TNIP1 | physical | 28514442 | |
| CE85L_HUMAN | CEP85L | physical | 28514442 | |
| HXC9_HUMAN | HOXC9 | physical | 28514442 | |
| RMD5B_HUMAN | RMND5B | physical | 28514442 | |
| ZMY19_HUMAN | ZMYND19 | physical | 28514442 | |
| ARMC8_HUMAN | ARMC8 | physical | 28514442 | |
| PIGS_HUMAN | PIGS | physical | 28514442 | |
| MKLN1_HUMAN | MKLN1 | physical | 28514442 | |
| RMD5A_HUMAN | RMND5A | physical | 28514442 | |
| GID8_HUMAN | GID8 | physical | 28514442 | |
| MAEA_HUMAN | MAEA | physical | 28514442 | |
| RBP10_HUMAN | RANBP10 | physical | 28514442 | |
| GID4_HUMAN | GID4 | physical | 28514442 | |
| ZN609_HUMAN | ZNF609 | physical | 28514442 | |
| EGFL7_HUMAN | EGFL7 | physical | 28514442 | |
| RANB9_HUMAN | RANBP9 | physical | 28514442 | |
| N42L2_HUMAN | N4BP2L2 | physical | 28514442 | |
| WDR26_HUMAN | WDR26 | physical | 28514442 | |
| ANR40_HUMAN | ANKRD40 | physical | 28514442 | |
| BORA_HUMAN | BORA | physical | 28514442 | |
| PIGU_HUMAN | PIGU | physical | 28514442 | |
| STOM_HUMAN | STOM | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615398 | Multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) | |||||
| 615399 | Paroxysmal nocturnal hemoglobinuria 2 (PNH2) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-164, AND MASSSPECTROMETRY. | |